Shares of Abivax SA Sponsored ADR (ABVX) have gained 6.9% over the past four weeks to close the last trading session at $11.75, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $34.50 indicates a potential upside of 193.6%.The mean estimate comprises six short-term price targets with a standard deviation of $13.59. While the lowest estimate of $16 indicates a 36.2% increase from ...